Turn Therapeutics Inc. (TTRX) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 19Aug 24Aug 27Sep 1Sep 4Sep 10Sep 15Sep 18

Key dataSep 18, 2026

Open$13.80

From 52W high+0.00%

Volume929017.00

Market cap$453.69M

P/E (TTM)—

P/S (TTM)—

Div yield—

Key dataSep 18, 2026

Open

$13.80

From 52W high

+0.00%

Volume

929017.00

Market cap

$453.69M

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−107.9x

P/E (TTM)

—

RSI (14)

76.5

MomentumView details →

1D Return

+8.10%

YTD Return

+285.72%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−107.9x

EV/Sales

—

P/S (TTM)

—

P/B (TTM)

660.5x

ProfitabilityView details →

Gross Margin

—

Net Margin

—

EBITDA Margin

—

ROE (TTM)

−1229.58%

ROA (TTM)

−49.80%

Asset Turnover

0.00x

GrowthView details →

Revenue YoY

—

EPS YoY

—

FCF YoY

—

Revenue CAGR 3Y

—

EPS CAGR 3Y

−76.92%

EBITDA YoY

—

MomentumView details →

1D Return

+8.10%

YTD Return

+285.72%

1Y Return

—

RSI (14)

76.5

vs 50D SMA

+48.97%

vs 200D SMA

+163.04%

Capital & dividendView details →

Debt/Equity

8.91x

Current Ratio

1.19x

Quick Ratio

1.19x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.20

EPS Surprise

−900.00%

Beats (12Q)

0/12

Next Q EPS Est

−$0.09

Avg Surprise (4Q)

−342.16%

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

0.00

Net Income (TTM)

−8.45M

Op. CF (TTM)

−4.32M

Next earningsNov 12, 2026 →

Latest newsMore news →

Turn Therapeutics announced new peer-reviewed research showing its product GX-03 selectively reduces key drivers of skin inflammation and itch.31d ago

Turn Therapeutics Inc. completed the full cashless exercise of a warrant to purchase its common stock, issuing 579,664 shares of common stock to GEM Global Yield LLC SCS and GEM Yield Bahamas Limited at an exercise price of $5.03 per share, relying on the Section 4(a)(2) exemption for accredited investors.34d ago

Similar companies

Arcturus Therapeutics Holdings Inc.ARCT Genfit S.A.GNFT Kyverna Therapeutics, Inc.KYTX Prothena Corporation plcPRTA Relmada Therapeutics, Inc.RLMD Cutia Therapeutics02487.HK Find similar companies →

Latest newsMore news →

Turn Therapeutics announced new peer-reviewed research showing its product GX-03 selectively reduces key drivers of skin inflammation and itch.31d ago Turn Therapeutics Inc. completed the full cashless exercise of a warrant to purchase its common stock, issuing 579,664 shares of common stock to GEM Global Yield LLC SCS and GEM Yield Bahamas Limited at an exercise price of $5.03 per share, relying on the Section 4(a)(2) exemption for accredited investors.34d ago